Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors

Vikas Dembla, Roman Groisberg, Kenneth R Hess, Siqing Fu, Jennifer Jane Wheler, David S. Hong, Filip Janku, Ralph G Zinner, Sarina Anne Piha-Paul, Vinod Ravi, Robert S Benjamin, Shreyaskumar Patel, Neeta Somaiah, Cynthia E. Herzog, Daniel D. Karp, Jason Roszik, Funda Meric-Bernstam, Vivek Subbiah

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences